![NPS-2143-SB-262470A-DataSheet-生命科學試劑-MedChemExpress_第1頁](http://file4.renrendoc.com/view/6653bf55e60b4f3e343c06c0b4db615c/6653bf55e60b4f3e343c06c0b4db615c1.gif)
![NPS-2143-SB-262470A-DataSheet-生命科學試劑-MedChemExpress_第2頁](http://file4.renrendoc.com/view/6653bf55e60b4f3e343c06c0b4db615c/6653bf55e60b4f3e343c06c0b4db615c2.gif)
![NPS-2143-SB-262470A-DataSheet-生命科學試劑-MedChemExpress_第3頁](http://file4.renrendoc.com/view/6653bf55e60b4f3e343c06c0b4db615c/6653bf55e60b4f3e343c06c0b4db615c3.gif)
![NPS-2143-SB-262470A-DataSheet-生命科學試劑-MedChemExpress_第4頁](http://file4.renrendoc.com/view/6653bf55e60b4f3e343c06c0b4db615c/6653bf55e60b4f3e343c06c0b4db615c4.gif)
下載本文檔
版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemENPS-2143Cat. No.: HY-10007CAS No.: 284035-33-2Synonyms: SB 262470A分式: CHClNO分量: 408.92作靶點: CaSR作通路: GPCR/G Protein儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 100 mg/mL (244.55 mM)* mean
2、s soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.4455 mL 12.2273 mL 24.4547 mL5 mM 0.4891 mL 2.4455 mL 4.8909 mL10 mM 0.2445 mL 1.2227 mL 2.4455 mL請根據(jù)產品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內實驗 請根據(jù)您的實驗動物和給藥式選擇適當?shù)娜芙獍?,配制前請先配制澄清的儲備液,再依次添加助溶?為保證實驗結果的可靠性,體內實驗的作液,建
3、議您現(xiàn)現(xiàn)配,當天使;澄清的儲備液可以根據(jù)儲存條件,適當保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.11 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (6.11 mM); Clear solution1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEBIOLOGICA
4、L ACTIVITY物活性 NPS-2143是選擇性的鈣敏感受體 (CaSR) 拮抗劑,IC50 為 43 nM。IC50 & Target IC50: 43 nM (Ca2+ receptor)體外研究 NPS-2143 blocks increases in cytoplasmic Ca2+ concentrations with IC50 of 43 nM elicited by activating theCa2+ receptor in HEK 293 cells expressing the human Ca2+ receptor. NPS-2143 stimulates para
5、thyroidhormone (PTH) secretion from bovine parathyroid cells with EC50 of 41 nM. Moreover, NPS 214 also blocksthe inhibitory effects of calcimimetic NPS R-467 on PTH secretion from bovine parathyroid cells and theinhibitory effects of extracellular Ca2+ on isoproterenol-stimulated increases in cycli
6、c AMP formation 1. InHEK-293 cells transiently expressing hCaSRs, NPS-2143 significantly suppresses the kokumi taste byeffectively inhibiting the activity of both GSH and -Glu-Val-Gly 3. A recent study shows that NPS-2143treatment suppresses low molecular weight fractions of azuki hydrolysate-induce
7、d cholecystokinin (CCK)secretion in CaSR-transfected HEK 293 cells 4.體內研究 NPS-2143 results in a rapid 4- to 5-fold increase in plasma PTH levels and also a transient increase inplasma Ca2+ levels 1 in rats. In normotensive rats, NPS-2143 administration (1 mg/kg, i.v.) markedlyincreases mean arterial
8、 blood pressure (MAP) in the presence of parathyroid glands 2.PROTOCOLKinase Assay 1 This clonal cell line, referred to as HEK 293 4.0-7 cells, are used in a high-throughput screening format todetect agonists and allosteric activators of the Ca2+ receptor. Changes in the concentration of cytoplasmic
9、Ca2+i provide a quantitative and functional assessment of Ca2+ receptor activity in these cells and theresults using this assay parallel those obtained using a homologous expression system of bovine parathyroidcells. On-line continuous measurements of fluorescence in fluo-3- or fura-2-loaded HEK 293
10、 4.0-7 cells areobtained using a custom-built spectrofluorimeter or a fluorescence imaging plate reader instrument. NPS-2143 is incubated with cells for 1 minute before increasing the concentration of extracellular Ca2+ from 1.0mM to 1.75 mM. NPS-2143 is tested individually at a concentration of 100
11、 g/mL (20 M-80 M) and thosecausing more than a 40% inhibition of the control response are considered to be biologically active. Todetermine the potencies (IC50) of NPS-2143 with biological activity, concentration-response curves areobtained and then, as an initial assessment of selectivity, the effe
12、cts of NPS-2143 on Ca2+i evoked by otherG protein-coupled receptors are examined at a concentration several times their IC50. Wild-type HEK 293cells (and HEK 293 4.0-7 cells) express receptors for thrombin, bradykinin, and ATP, which couple to themobilization of intracellular Ca2+. These responses c
13、an be studied to quickly assess any nonselective actionof compounds on G protein-coupled receptors. Additional assays for selectivity include HEK 293 cellsengineered to express receptors most homologous in sequence and topology to the Ca2+ receptor. Theseinclude native or chimeric receptors for vari
14、ous metabotropic glutamate and -aminobutyric acid type Breceptors (GABABRs). Chimeric receptors are created using partial sequences of metabotropic glutamatereceptors and Ca2+ receptors, engineered to couple to activation of phospholipase C and release ofintracellular Ca2+ in HEK 293 cells. NPS-2143
15、 lacking pan-activity are then subjected to structural2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEmodifications and their potencies and selectivities monitored using these HEK 293 4.0-7 cell assays in aniterative process.MCE has not independently confirmed the accuracy of these methods. They ar
16、e for reference only.Animal Rats: On the day of study, the rats are infused intravenously (0.1 mL/kgmin) for 120 min with NPS-2143 (0.1Administration 1 mol/kgmin) or vehicle, a 20% aqueous solution of 2-hydroxypropyl-cyclodextrin. Blood samples (0.5 mL)are collected before and at various times after
17、 the start of the infusion for measurements of plasma levels ofPTH and Ca2+. To prevent excessive blood volume loss during the course of the experiment, for each bloodsample the erythrocyte pellet is resuspended in an equal volume of normal rat plasma and reinjected.Plasma levels of Ca2+ are measure
18、d immediately after collection using a model 634 ionized calciumanalyzer. PTH levels are measured using the Immutopics rat PTH(1-34) immunoradiometric assay kit.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產品發(fā)表的科研獻 Oxid Med Cell Longev. 2017;2017:
19、3869561. Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1309-17. Gen Comp Endocrinol. 2018 Oct 1;267:1-8. J Food Sci. 2018 Sep;83(9):2394-2401. J Vet Sci. 2018 Mar 31;19(2):179-187.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Nemeth EF, et al. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroidhormone. J Pharmacol Exp Ther. 2001 Oct;299(1):323-31.2. Rybczynska A, et al. Hypertensive effect of calcilytic NPS 2143 administration in rats. J Endocrinol. 2006 Oct;191(1):189-95.3. Oh
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年節(jié)能高效果汁濃縮設備項目申請報告模板
- 2025年個體之間土地轉讓策劃合同樣本
- 2025年倉儲租賃安全條款協(xié)議示范
- 2025年買賣雙方貨物運輸合同書
- 2025年專賣店裝潢工程合同
- 2025年會員費用結算示例協(xié)議
- 2025年公寓樓建筑項目合同示例
- 2025年企業(yè)員工租賃住房協(xié)議模版
- 2025年個人擔保契約協(xié)議書
- 2025年保安人員租賃合作協(xié)議
- 慢性胰腺炎課件
- 北京理工大學應用光學課件第四章
- 陰道鏡幻燈課件
- 2022年山東司法警官職業(yè)學院單招語文試題及答案解析
- PCB行業(yè)安全生產常見隱患及防范措施課件
- 2023版北京協(xié)和醫(yī)院重癥醫(yī)學科診療常規(guī)
- DB32∕T 186-2015 建筑消防設施檢測技術規(guī)程
- 2022年福建泉州中考英語真題【含答案】
- 汽車座椅骨架的焊接夾具畢業(yè)設計說明書(共23頁)
- 露天礦山職業(yè)危害預先危險分析表
- 淺談固定資產的審計
評論
0/150
提交評論